person · Reporting owner
O'Connor Padraig Andrew
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPBSX · Entity 1897 | EVP, Global Operations | September 02, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BOSTON SCIENTIFIC CORP
Report date September 02, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,459 |
Reported balance
After 2026-09-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-02 · Exercise / conversion · Acquired 1,171 · Balance 8,459 F1: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2: Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available. |
| Common StockSEC Table I · non-derivative | Direct | 7,892 |
Reported balance
After 2026-09-02 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-02 · Tax withholding · Disposed 567 · Balance 7,892 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2029-09-02 | Direct | 3,516 |
Reported balance
After 2026-09-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-02 · Exercise / conversion · Disposed 1,171 · Balance 3,516 F1: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F3: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.
F3: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2026 Filed Sep 3, 2026 20:34 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 1,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-007620 · doc4.xml · derivative · entry 3 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,516 Underlying: Common Stock · 1,171 shares Expires 2029-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F3 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant. F3 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant. Read SEC document |
| September 02, 2026 Filed Sep 3, 2026 20:34 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 567 | $48.37 | $27,425.79 |
DisclosureSEC source: 0001225208-26-007620 · doc4.xml · nonDerivative · entry 2 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,892 Read SEC document |
| September 02, 2026 Filed Sep 3, 2026 20:34 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-007620 · doc4.xml · nonDerivative · entry 1 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · balance_after: Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| May 02, 2026 Filed May 4, 2026 21:30 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 1,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004897 · doc4.xml · derivative · entry 3 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,802 shares Expires 2026-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant. Read SEC document |
| May 02, 2026 Filed May 4, 2026 21:30 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 872 | $56.50 | $49,268.00 |
DisclosureSEC source: 0001225208-26-004897 · doc4.xml · nonDerivative · entry 2 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,024 Read SEC document |
| May 02, 2026 Filed May 4, 2026 21:30 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004897 · doc4.xml · nonDerivative · entry 1 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 905 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002137 · doc4.xml · derivative · entry 9 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 905 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F4 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. F4 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 339 | $74.73 | $25,333.47 |
DisclosureSEC source: 0001225208-26-002137 · doc4.xml · nonDerivative · entry 6 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,094 Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 905 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002137 · doc4.xml · nonDerivative · entry 5 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,433 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 1,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002137 · doc4.xml · derivative · entry 8 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,190 Underlying: Common Stock · 1,190 shares Expires 2027-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F3 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant. F3 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 449 | $74.73 | $33,553.77 |
DisclosureSEC source: 0001225208-26-002137 · doc4.xml · nonDerivative · entry 4 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,528 Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002137 · doc4.xml · nonDerivative · entry 3 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002137 · doc4.xml · derivative · entry 7 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,502 Underlying: Common Stock · 500 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 199 | $74.73 | $14,871.27 |
DisclosureSEC source: 0001225208-26-002137 · doc4.xml · nonDerivative · entry 2 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,787 Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 22:58 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002137 · doc4.xml · nonDerivative · entry 1 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:07 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantStock Option (Right to Buy) · Derivative | 11,939 | $0.00 Strike: $74.12 | $0.00 |
DisclosureSEC source: 0001225208-26-002018 · doc4.xml · derivative · entry 5 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,939 Underlying: Common Stock · 11,939 shares Expires 2036-02-12 F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:07 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantRestricted Stock Units · Derivative | 5,059 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002018 · doc4.xml · derivative · entry 4 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,059 Underlying: Common Stock · 5,059 shares Expires 2030-02-12 F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F3 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant. F3 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:07 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionRestricted Stock Units · Derivative | 1,058 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002018 · doc4.xml · derivative · entry 3 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,116 Underlying: Common Stock · 1,058 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:07 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Tax withholdingCommon Stock | 457 | $74.12 | $33,872.84 |
DisclosureSEC source: 0001225208-26-002018 · doc4.xml · nonDerivative · entry 2 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,486 Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:07 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | Exercise / conversionCommon Stock | 1,058 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002018 · doc4.xml · nonDerivative · entry 1 O'Connor Padraig Andrew · CIK 0002098740 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.